INCURON

Pipeline

CBL137 Indication	Research	Pre-Clinical	Phase 1	Phase 2	Phase 3
Solid Tumors, IV administration, USA
Solid Tumors, Oral administration, RUS
Hematological Malignancies

The results of two completed clinical trials of the curaxin CBL0137 (oral and intravenous administration) in patients with advanced solid…

The results of the research which describe the curaxin CBL0137 mechanism of action will be presented at the American Association…

Incuron will be presenting as a Top Innovator at the Life Sciences Track of The 2019 New England Venture Summit.…

info@incuron.com

73 High Street, Buffalo, NY 14203
Telephone/Fax: (716) 588-0007